XT
FLNA

XTX Topco’s Filana Therapeutics FLNA Stock Holding History

XTX Topco’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.3K Sell
33,303
-1,625
-5% -$3.35K ﹤0.01% 3285
2025
Q4 		$69.2K Sell
34,928
-53,635
-61% -$172K ﹤0.01% 2748
2025
Q3 		$258K Buy
88,563
+42,152
+91% +$96.9K 0.01% 1625
2025
Q2 		$84K Sell
46,411
-6,723
-13% -$12K ﹤0.01% 1916
2025
Q1 		$79.7K Sell
53,134
-40,279
-43% -$102K ﹤0.01% 1912
2024
Q4 		$220K Buy
+93,413
New +$1.64M 0.02% 1478
2024
Q1 		– Sell
-12,723
Closed -$286K – 2266
2023
Q4 		$286K Buy
+12,723
New +$269K 0.06% 661

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

XTX Topco's FLNA Position: Q1 2026 in Review

XTX Topco reduced its Filana Therapeutics (FLNA) stake by 4.7% in Q1 2026, selling an estimated $3.35K and leaving 33,303 shares worth $56.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3285.

XTX Topco first reported a position in FLNA in Q4 2023 and has held it in 7 quarters since. The position peaked at $286K in Q4 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • XTX Topco held 33,303 shares of Filana Therapeutics worth $56.3K as of Q1 2026.
  • XTX Topco sold 1,625 Filana Therapeutics shares in Q1 2026, an estimated $3.35K.
  • Filana Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3285 holding.
  • XTX Topco first reported a position in Filana Therapeutics in Q4 2023 and has held it in 7 quarters since.
  • XTX Topco's Filana Therapeutics position peaked at $286K in Q4 2023.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.